Variability in Serum Sodium Concentration and Prognostic Significance in Severe Traumatic Brain Injury: A Multicenter Observational Study.


Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
06 2021
Historique:
received: 19 03 2020
accepted: 15 09 2020
pubmed: 4 10 2020
medline: 30 9 2021
entrez: 3 10 2020
Statut: ppublish

Résumé

Dysnatremia is common in severe traumatic brain injury (TBI) patients and may contribute to mortality. However, serum sodium variability has not been studied in TBI patients. We hypothesized that such variability would be independently associated with mortality. We collected 6-hourly serum sodium levels for the first 7 days of ICU admission from 240 severe TBI patients in 14 neurotrauma ICUs in Europe and Australia. We evaluated the association between daily serum sodium standard deviation (dNa Patients were 46 ± 19 years of age with a median initial GCS of 6 [4-8]. Overall hospital mortality was 28%. Hypernatremia and hyponatremia occurred in 64% and 24% of patients, respectively. Over the first 7 days in ICU, serum sodium standard deviation was 2.8 [2.0-3.9] mmol/L. Maximum daily serum sodium standard deviation (dNa Our study demonstrates that daily serum sodium variability is an independent predictor of 28-day mortality in severe TBI patients. Further prospective investigations are necessary to confirm the significance of sodium variability in larger cohorts of TBI patients and test whether attenuating such variability confers outcome benefits to such patients.

Sections du résumé

BACKGROUND/OBJECTIVE
Dysnatremia is common in severe traumatic brain injury (TBI) patients and may contribute to mortality. However, serum sodium variability has not been studied in TBI patients. We hypothesized that such variability would be independently associated with mortality.
METHODS
We collected 6-hourly serum sodium levels for the first 7 days of ICU admission from 240 severe TBI patients in 14 neurotrauma ICUs in Europe and Australia. We evaluated the association between daily serum sodium standard deviation (dNa
RESULTS
Patients were 46 ± 19 years of age with a median initial GCS of 6 [4-8]. Overall hospital mortality was 28%. Hypernatremia and hyponatremia occurred in 64% and 24% of patients, respectively. Over the first 7 days in ICU, serum sodium standard deviation was 2.8 [2.0-3.9] mmol/L. Maximum daily serum sodium standard deviation (dNa
CONCLUSIONS
Our study demonstrates that daily serum sodium variability is an independent predictor of 28-day mortality in severe TBI patients. Further prospective investigations are necessary to confirm the significance of sodium variability in larger cohorts of TBI patients and test whether attenuating such variability confers outcome benefits to such patients.

Identifiants

pubmed: 33009658
doi: 10.1007/s12028-020-01118-8
pii: 10.1007/s12028-020-01118-8
doi:

Substances chimiques

Sodium 9NEZ333N27

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

899-907

Investigateurs

K Long (K)
A Rodrigues (A)
A Lozano (A)
E Saxby (E)
A Vargiolu (A)
H Quintard (H)
M Guillemes (M)
A Sisson (A)
G Allen (G)
N Baro (N)
M Kofler (M)

Références

Kleindienst A, Hannon MJ, Buchfelder M, Verbalis JG. Hyponatremia in neurotrauma: the role of vasopressin. J Neurotrauma. 2016;33:615–24.
doi: 10.1089/neu.2015.3981
Maggiore U, Picetti E, Antonucci E, Parenti E, Regolisti G, Mergoni M, et al. The relation between the incidence of hypernatremia and mortality in patients with severe traumatic brain injury. Crit Care Lond Engl. 2009;13:R110.
doi: 10.1186/cc7953
Aiyagari V, Deibert E, Diringer MN. Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care. 2006;21:163–72.
doi: 10.1016/j.jcrc.2005.10.002
Moro N, Katayama Y, Igarashi T, Mori T, Kawamata T, Kojima J. Hyponatremia in patients with traumatic brain injury: incidence, mechanism, and response to sodium supplementation or retention therapy with hydrocortisone. Surg Neurol. 2007;68:387–93.
doi: 10.1016/j.surneu.2006.11.052
Lescot T, Degos V, Zouaoui A, Préteux F, Coriat P, Puybasset L. Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med. 2006;34:3029–33.
doi: 10.1097/01.CCM.0000243797.42346.64
Melton JE, Patlak CS, Pettigrew KD, Cserr HF. Volume regulatory loss of Na, Cl, and K from rat brain during acute hyponatremia. Am J Physiol. 1987;252:F661–9.
pubmed: 3565577
Verbalis JG. Brain volume regulation in response to changes in osmolality. Neuroscience. 2010;168:862–70.
doi: 10.1016/j.neuroscience.2010.03.042
Sakr Y, Rother S, Ferreira AMP, Ewald C, Dünisch P, Riedemmann N, et al. Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med. 2013;41:133–42.
doi: 10.1097/CCM.0b013e318265f576
Ye X, Kooman JP, van der Sande FM, Canaud B, Stuard S, Etter M, et al. Increased mortality associated with higher pre-dialysis serum sodium variability: results of the international monitoring dialysis outcome initiative. Am J Nephrol. 2019;49:1–10.
doi: 10.1159/000495354
Anstey J, Taccone F, Udy A, Citerio G, Duranteau J, Ichai C, et al. Early osmotherapy in severe traumatic brain injury: an international multicentre study. J Neurotrauma. 2020;37:178–84.
doi: 10.1089/neu.2019.6399
Sterns RH. Disorders of plasma sodium—causes, consequences, and correction. N Engl J Med. 2015;372:55–65.
doi: 10.1056/NEJMra1404489
Harrois A, Anstey JR, Taccone FS, Udy AA, Citerio G, The TBI Collaborative, et al. Serum sodium and intracranial pressure changes after desmopressin therapy in severe traumatic brain injury patients: a multi-centre cohort study. Ann Intensive Care. 2019;9:99.
doi: 10.1186/s13613-019-0574-z
Yumoto T, Sato K, Ugawa T, Ichiba S, Ujike Y. Prevalence, risk factors, and short-term consequences of traumatic brain injury-associated hyponatremia. Acta Med Okayama. 2015;69:213–8.
pubmed: 26289912
Shintani AK, Girard TD, Eden SK, Arbogast PG, Moons KGM, Ely EW. Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies. Crit Care Med. 2009;37:2939–45.
doi: 10.1097/CCM.0b013e3181b7fbbb
Huque MH, Carlin JB, Simpson JA, Lee KJ. A comparison of multiple imputation methods for missing data in longitudinal studies. BMC Med Res Methodol. 2018;18:168.
doi: 10.1186/s12874-018-0615-6
Kleindienst A, Brabant G, Morgenthaler NG, Dixit KC, Parsch H, Buchfelder M. Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregulation but correlates with injury severity. Acta Neurochir Suppl. 2010;106:221–4.
doi: 10.1007/978-3-211-98811-4_41
Hannon MJ, Crowley RK, Behan LA, O’Sullivan EP, O’Brien MMC, Sherlock M, et al. Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality. J Clin Endocrinol Metab. 2013;98:3229–37.
doi: 10.1210/jc.2013-1555
Agha A, Thornton E, O’Kelly P, Tormey W, Phillips J, Thompson CJ. Posterior pituitary dysfunction after traumatic brain injury. J Clin Endocrinol Metab. 2004;89:5987–92.
doi: 10.1210/jc.2004-1058
Harrois A, Anstey JR. Diabetes insipidus and syndrome of inappropriate antidiuretic hormone in critically ill patients. Crit Care Clin. 2019;35:187–200.
doi: 10.1016/j.ccc.2018.11.001
Human T, Cook AM, Anger B, Bledsoe K, Castle A, Deen D, et al. Treatment of hyponatremia in patients with acute neurological injury. Neurocrit Care. 2017;27:242–8.
doi: 10.1007/s12028-016-0343-x
Lohani S, Devkota UP. Hyponatremia in patients with traumatic brain injury: etiology, incidence, and severity correlation. World Neurosurg. 2011;76:355–60.
doi: 10.1016/j.wneu.2011.03.042
Meng X, Shi B. Traumatic brain injury patients with a glasgow coma scale score of ≤ 8, cerebral edema, and/or a basal skull fracture are more susceptible to developing hyponatremia. J Neurosurg Anesthesiol. 2016;28:21–6.
doi: 10.1097/ANA.0000000000000192
Vedantam A, Robertson CS, Gopinath SP. Morbidity and mortality associated with hypernatremia in patients with severe traumatic brain injury. Neurosurg Focus. 2017;43:E2.
doi: 10.3171/2017.7.FOCUS17418
Li M, Hu YH, Chen G. Hypernatremia severity and the risk of death after traumatic brain injury. Injury. 2013;44:1213–8.
doi: 10.1016/j.injury.2012.05.021
Asehnoune K, Lasocki S, Seguin P, Geeraerts T, Perrigault PF, Dahyot-Fizelier C, et al. Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury—a multicentre prospective cohort study and systematic review. Crit Care. 2017;21:328.
doi: 10.1186/s13054-017-1918-4
Wells DL, Swanson JM, Wood GC, Magnotti LJ, Boucher BA, Croce MA, et al. The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma. Crit Care Lond Engl. 2012;16:R193.
doi: 10.1186/cc11678
Sen S, Tran N, Chan B, Palmieri TL, Greenhalgh DG, Cho K. Sodium variability is associated with increased mortality in severe burn injury. Burns Trauma. 2017;5:34.
pubmed: 29142896 pmcid: 5674226
Stelfox HT, Ahmed SB, Zygun D, Khandwala F, Laupland K. Characterization of intensive care unit acquired hyponatremia and hypernatremia following cardiac surgery. Can J Anaesth J Can Anesth. 2010;57:650–8.
doi: 10.1007/s12630-010-9309-1
Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Laupland K. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care Lond Engl. 2008;12:R162.
doi: 10.1186/cc7162
Cooper DJ, Myburgh J, Heritier S, Finfer S, Bellomo R, Billot L, et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma. 2013;30:512–8.
doi: 10.1089/neu.2012.2573

Auteurs

Anatole Harrois (A)

Intensive Care Unit, Royal Melbourne Hospital, Level 5, B Block, Parkville, VIC, 3050, Australia. harroisanatole@yahoo.fr.
Department of Anesthesia and Surgical Intensive Care, Paris Sud University, CHU de Bicetre, Le Kremlin Bicêtre, 78, rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France. harroisanatole@yahoo.fr.

James R Anstey (JR)

Intensive Care Unit, Royal Melbourne Hospital, Level 5, B Block, Parkville, VIC, 3050, Australia.

Mathieu van der Jagt (M)

Department of Intensive Care Adults, Erasmus MC-University Medical Center, Dr Molewaterplein 40, 3015 GD, Po Box 2040, 3000 CA, Rotterdam, The Netherlands.

Fabio S Taccone (FS)

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.

Andrew A Udy (AA)

Intensive Care Unit, The Alfred Hospital, Main Ward Block, Level 1, Commercial Road, Melbourne, VIC, 3004, Australia.
Australian and New Zealand Intensive Care Research Center, School of Public Health and Preventative Medicine, ANZIC-RC, Department of Epidemiology and Preventive Medicine, Monash University, Level 3, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.

Giuseppe Citerio (G)

School of Medicine and Surgery, University Milano Bicocca - Neurointensive Care, San Gerardo Hospital, ASST-Monza, Monza, Italy.

Jacques Duranteau (J)

Department of Anesthesia and Surgical Intensive Care, Paris Sud University, CHU de Bicetre, Le Kremlin Bicêtre, 78, rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France.

Carole Ichai (C)

Center hospitalier Universitaire de Nice, Service de Réanimation polyvalente, Hôpital Pasteur 2, CHU de Nice, Université Côte d'Azur, 30 Voie Romaine, 06000, Nice, France.

Rafael Badenes (R)

Department of Anesthesiology and Surgical-Trauma Intensive Care, Hospital Clinic Universitari de Valencia, Department of Surgery, University of Valencia, Valencia, Spain.

John R Prowle (JR)

Adult Critical Care Unit, The Royal London Hospital, Barts Health NHS Trust, Royal London Hospital, Whitechapel Road, London, E1 1BB, UK.

Ari Ercole (A)

Neurosciences and Trauma Critical Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Mauro Oddo (M)

Department of Medical-Surgical Intensive Care Medicine, Faculty of Biology and Medicine, Center Hospitalier Universitaire, Vaudois (CHUV), University of Lausanne, 1011, Lausanne, Switzerland.

Antoine Schneider (A)

Department of Medical-Surgical Intensive Care Medicine, Faculty of Biology and Medicine, Center Hospitalier Universitaire, Vaudois (CHUV), University of Lausanne, 1011, Lausanne, Switzerland.

Stefan Wolf (S)

Department of Neurosurgery, Charité Universitätsmedizin Neuro Intensive Care Unit 102i, Campus Charité Mitte (CCM), Charitéplatz 1, 10117, Berlin, Germany.

Raimund Helbok (R)

Neurocritical Care Unit, Department of Neurology, Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

David W Nelson (DW)

Section for Perioperative Medicine and Intensive Care, Department of Physiology and Pharmacology, Karolinska Institute, 171 76, Stockholm, Sweden.

D Jamie Cooper (DJ)

Intensive Care Unit, The Alfred Hospital, Main Ward Block, Level 1, Commercial Road, Melbourne, VIC, 3004, Australia.
Australian and New Zealand Intensive Care Research Center, School of Public Health and Preventative Medicine, ANZIC-RC, Department of Epidemiology and Preventive Medicine, Monash University, Level 3, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.

Rinaldo Bellomo (R)

Intensive Care Unit, Royal Melbourne Hospital, Level 5, B Block, Parkville, VIC, 3050, Australia.
Australian and New Zealand Intensive Care Research Center, School of Public Health and Preventative Medicine, ANZIC-RC, Department of Epidemiology and Preventive Medicine, Monash University, Level 3, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.
Department of Intensive Care, Austin Health, 145 Studley Rd, Heidelberg, Melbourne, VIC, Australia.
Center for Integrated Critical Care, School of Medicine, University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH